Imatinib for Pain in Sickle Cell Anemia

Clinical trial NCT03997903 · TERMINATED

Trial details

NCT number: NCT03997903
Sponsor: Indiana University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2020-02-26
Primary completion: 2024-08-06
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.